BioTek Receives Extraordinary New Product Line Award from Fisher
News Mar 04, 2014
BioTek Instruments, Inc. has received Thermo Fisher Scientific's "Extraordinary New Product Line" award for their Cytation 3 Cell Imaging Multi-Mode Reader.
The award was presented at the Fisher Scientific North America Sales Meeting, held February 24-26, 2014 in Denver, Colorado.
Cytation 3 was recognized by Fisher Scientific's product management team for its innovative technology and successful sales performance.
"We're proud to have Fisher Scientific as a strong partner, and honored to receive this award," noted Gary Barush, Director of Marketing and Sales at BioTek Instruments. "Together, and with Cytation 3's combination of cellular imaging and multi-mode microplate detection, we can continue to provide unique workflow solutions to any laboratory."
BioTek's patent pending Cytation™ 3 Cell Imaging Multi-Mode Reader combines automated digital fluorescence microscopy and conventional microplate detection in a modular and upgradable platform.
This allows for quantitative and phenotypic cellular analyses, and especially for live cell assays where Cytation 3's temperature control and available gas control module support the ideal environment to grow, image, count and further analyze cells in microplates and other sample vessels.
Cytation 3 is the recipient of two additional awards since its launch: MipTec New Product Innovation Award and the SelectScience "Scientists' Choice Award for Best Drug Discovery Product" Award. It is also a finalist in the 2014 Edison Awards® competition.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018